Evidence map›Paper›PMID 41160486›Full record

ArticleThe British journal of radiology2025

Severe anaphylactic reaction to contrast agent: teams are well prepared but should simulate the situations regularly.

Karl-Christian Pape, Matthias Meissnitzer, Zoe Strüby, Thomas Sartoretti, Dorothee Harder, Simon Matoori, Johannes M Froehlich, Sebastian Schindera, Simin Laures, Christophe Hälg and 9 more

Abstract read
In one paragraph

Article in The British journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Karl-Christian PapeDepartment of Health Sciences and Medicine, University of Lucerne, 6002 Lucerne, Switzerland.ORCID 0009-0005-5161-5974
Matthias MeissnitzerDepartment of Radiology, Röntgen Mirabell, Gruppenpraxis Radiologie, 5020 Salzburg, Austria.
Zoe StrübyDepartment of Health Sciences and Medicine, University of Lucerne, 6002 Lucerne, Switzerland.
Thomas SartorettiFaculty of Medicine, University of Zurich, 8032 Zurich, Switzerland.
Dorothee HarderDepartment of Health Sciences and Medicine, University of Lucerne, 6002 Lucerne, Switzerland.
Simon MatooriFaculté de Pharmacie, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Johannes M FroehlichDepartment of Health Sciences and Medicine, University of Lucerne, 6002 Lucerne, Switzerland.
Sebastian SchinderaDepartment of Radiology, Kantonsspital Aarau, 5000 Aarau, Switzerland.
Simin LauresDepartment of Radiology, Kantonsspital Aarau, 5000 Aarau, Switzerland.
Christophe HälgDepartment of Radiology, Kantonsspital Aarau, 5000 Aarau, Switzerland.
Klaus HerganDepartment of Radiology, Röntgen Mirabell, Gruppenpraxis Radiologie, 5020 Salzburg, Austria.
Stefan HechtDepartment of Radiology, Röntgen Mirabell, Gruppenpraxis Radiologie, 5020 Salzburg, Austria.
Christoph KonradDepartment of Anaesthesiology, Luzerner Kantonsspital, Lucerne, 6000, Switzerland.
Oliver HausmannAllergy Unit, Zieglerspital, Clinic of Internal Medicine, Spital Netz Bern AG, 3007, Switzerland.
Jochen ElfgenDepartment of Health Sciences and Medicine, University of Lucerne, 6002 Lucerne, Switzerland.
Arash NajafiDepartment of Radiology and Nuclear Medicine, Kantonsspital Winterthur, 8401 Winterthur, Switzerland.
Rasmus Bech-HohenbergerDepartment of Health Sciences and Medicine, University of Lucerne, 6002 Lucerne, Switzerland.
Dow Mu KohCancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research, Sutton SM2 5PT, United Kingdom.
Andreas GutzeitDepartment of Health Sciences and Medicine, University of Lucerne, 6002 Lucerne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAnaphylactic reactions are dramatic and life-threatening. According to international guidelines, the immediate intramuscular administration of adrenaline is the most important first step for acute management. The aim of this study is to determine whether doctors can recognize and treat severe anaphylactic reactions to contrast agents adequately.

methodsIn this study, 95 doctors were interviewed between January and June 2023 in European clinics that are not affiliated with the authors. Ninety-five doctors from radiology, internal medicine, and anaesthesia departments were randomly selected for interviews. A video was prepared simulating a male patient developing a severe anaphylactic reaction during CT after intravenous administration of an iodinated contrast medium. After the video, 95 doctors were interviewed (59 radiologists, 19 internists, and 17 anaesthesiologists). The doctors were asked 3 questions: (1) What is the diagnosis? (2) What is the therapy of choice? (3) Can you demonstrate the correct way to operate the adrenaline autoinjector?

resultsAll 95 doctors made the correct diagnosis (100%). Sixty-three of 95 physicians (66%) were uncertain regarding the appropriate first-line therapy. This was observed across all three medical specialties (internal medicine, anaesthesiology, and radiology) (P = .64). Sixty-five physicians (68%) had difficulties triggering the autoinjection system successfully.

conclusionsAcute anaphylaxis is life-threatening, but there is uncertainty among professional groups about initiating acute management. Refresher training should be considered to ensure timely and appropriate treatment of the condition when it occurs. ADVANCES IN KNOWLEDGE: This study highlighted significant gaps in physicians' real-world readiness to manage acute anaphylaxis, despite all doctors correctly diagnosing the condition.

Indexed as

AnaphylaxisClinical CompetenceContrast MediaAdultEpinephrineFemaleHumansMaleMiddle AgedContrast MediaEpinephrineadrenalineanaphylaxisautoinjector

Identifiers

PMID41160486
PMCPMC12810879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.